NCOA4 and thyroid cancer: In conclusion, the significance of siRNA RET/PTC3-SQ NPs have been demonstrated in preclinical studies for thyroid cancer therapy and further pharmacological and clinical investigations can be proceeded to set-in the remedy of thyroid carcinoma.